Search all trials

Find therapies in clinical trials near you – page 20

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Warm autoimmune haemolytic anaemia+1

Not recruiting

Registered drugNo placebo

Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Danazol

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drugNo placebo

A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Not recruiting

Registered drugNo placebo

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

A study testing zimberelimab, domvanalimab, and sacituzumab govitecan for patients with PD-L1 positive advanced triple-negative breast cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Domvanalimab

Contact Research Centre

Malignant melanoma stage IV+1

Not recruiting

Registered drugNo placebo

Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Acasunlimab

Contact Research Centre

Immune thrombocytopenia

Not recruiting

Registered drug

A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Eltrombopag

Contact Research Centre

Chronic kidney disease+1

Not recruiting

Investigational

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Acute myocardial infarction

Not recruiting

Investigational

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Registered drugNo placebo

Study of JSB462 and lutetium (177Lu) vipivotide tetraxetan combination for adult men with PSMA-positive metastatic castration resistant prostate cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Gozetotide

Contact Research Centre

Cystic fibrosis respiratory infection suppression

Not recruiting

Investigational

Study of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:IHMA-2121771-1

Contact Research Centre

Find therapies in clinical trials near you – page 20

442 trials match your criteria

Colorectal cancer metastatic

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Warm autoimmune haemolytic anaemia+1

Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

Multiple sclerosis

A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Triple negative breast cancer

A study testing zimberelimab, domvanalimab, and sacituzumab govitecan for patients with PD-L1 positive advanced triple-negative breast cancer

Malignant melanoma stage IV+1

Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

Malignant melanoma

Study of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment

Immune thrombocytopenia

A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

Chronic kidney disease+1

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Acute myocardial infarction

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Prostate cancer metastatic

Study of JSB462 and lutetium (177Lu) vipivotide tetraxetan combination for adult men with PSMA-positive metastatic castration resistant prostate cancer

Cystic fibrosis respiratory infection suppression

Study of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.